The E2F transcription factor is a cellular target for the RB protein. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR (1991) Cell 65: 1053-61 TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Münger K, Howley PM, Moses HL (1990) Cell 61: 777-85 Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Mudryj M, Devoto SH, Hiebert SW, Hunter T, Pines J, Nevins JR (1991) Cell 65: 1243-53 Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study. Kreimer AR, Brennan P, Lang Kuhs KA, Waterboer T, Clifford G, Franceschi S, Michel A, Willhauck-Fleckenstein M, Riboli E, Castellsagué X, Hildesheim A, Fortner RT, Kaaks R, Palli D, Ljuslinder I, Panico S, Clavel-Chapelon F, Boutron-Ruault MC, Mesrine S, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, Cross AJ, Bueno-de-Mesquita HB, Vineis P, Larrañaga N, Pala V, Sánchez MJ, Navarro C, Barricarte A, Tumino R, Khaw KT, Wareham N, Boeing H, Steffen A, Travis RC, Quirós JR, Weiderpass E, Pawlita M, Johansson M (2015) J Clin Oncol 33: 877-84 Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer. Kreimer AR, Johansson M, Yanik EL, Katki HA, Check DP, Lang Kuhs KA, Willhauck-Fleckenstein M, Holzinger D, Hildesheim A, Pfeiffer R, Williams C, Freedman ND, Huang WY, Purdue MP, Michel A, Pawlita M, Brennan P, Waterboer T (2017) J Natl Cancer Inst 109: The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Lee DK, Park SH, Yi Y, Choi SG, Lee C, Parks WT, Cho H, de Caestecker MP, Shaul Y, Roberts AB, Kim SJ (2001) Genes Dev 15: 455-66 A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. Mudryj M, Hiebert SW, Nevins JR (1990) EMBO J 9: 2179-84 E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Hiebert SW, Lipp M, Nevins JR (1989) Proc Natl Acad Sci U S A 86: 3594-8 p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Slebos RJ, Lee MH, Plunkett BS, Kessis TD, Williams BO, Jacks T, Hedrick L, Kastan MB, Cho KR (1994) Proc Natl Acad Sci U S A 91: 5320-4 Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Kessis TD, Slebos RJ, Nelson WG, Kastan MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR (1993) Proc Natl Acad Sci U S A 90: 3988-92 Expression of the adenovirus E1A oncogene during cell transformation is sufficient to induce susceptibility to lysis by host inflammatory cells. Cook JL, Walker TA, Lewis AM, Ruley HE, Graham FL, Pilder SH (1986) Proc Natl Acad Sci U S A 83: 6965-9 Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival. Gubanova E, Brown B, Ivanov SV, Helleday T, Mills GB, Yarbrough WG, Issaeva N (2012) Clin Cancer Res 18: 1257-67 myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation. Maruyama K, Schiavi SC, Huse W, Johnson GL, Ruley HE (1987) Oncogene 1: 361-7 Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes. Kohl NE, Ruley HE (1987) Oncogene 2: 41-8 Mechanisms of oncogene cooperation: activation and inactivation of a growth antagonist. Ragozzino MM, Kuo A, DeGregori J, Kohl N, Ruley HE (1991) Environ Health Perspect 93: 97-103 Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells. Zerler B, Moran B, Maruyama K, Moomaw J, Grodzicker T, Ruley HE (1986) Mol Cell Biol 6: 887-99 Insulin gene enhancer activity is inhibited by adenovirus 5 E1a gene products. Stein RW, Whelan J (1989) Mol Cell Biol 9: 4531-4 Adenovirus E1A-mediated negative control of genes activated during F9 differentiation. Young KS, Weigel R, Hiebert S, Nevins JR (1989) Mol Cell Biol 9: 3109-13 Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer. Lang Kuhs KA, Wood CB, Wiggleton J, Aulino JM, Latimer B, Smith DK, Bender N, Rohde S, Mannion K, Kim Y, Sinard R, Langerman A, Fleischer A, Fakhry C, Waterboer T, Netterville JL (2020) Cancer 126: 2658-2665 Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence. Lang Kuhs KA, Kreimer AR, Trivedi S, Holzinger D, Pawlita M, Pfeiffer RM, Gibson SP, Schmitt NC, Hildesheim A, Waterboer T, Ferris RL (2017) Cancer 123: 4382-4390 Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. Stein RW, Corrigan M, Yaciuk P, Whelan J, Moran E (1990) J Virol 64: 4421-7 Two regions of the adenovirus early region 1A proteins are required for transformation. Whyte P, Ruley HE, Harlow E (1988) J Virol 62: 257-65 The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. Filippova M, Song H, Connolly JL, Dermody TS, Duerksen-Hughes PJ (2002) J Biol Chem 277: 21730-9 Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A Pooled Analysis. Lang Kuhs KA, Anantharaman D, Waterboer T, Johansson M, Brennan P, Michel A, Willhauck-Fleckenstein M, Purdue MP, Holcátová I, Ahrens W, Lagiou P, Polesel J, Simonato L, Merletti F, Healy CM, Kjaerheim K, Conway DI, Macfarlane TV, Thomson P, Castellsagué X, Znaor A, Black A, Huang WY, Krogh V, Trichopoulou A, Bueno-de-Mesquita HB, Clavel-Chapelon F, Weiderpass E, Ekström J, Riboli E, Tjønneland A, Sánchez MJ, Travis RC, Hildesheim A, Pawlita M, Kreimer AR (2015) Cancer Epidemiol Biomarkers Prev 24: 683-9 Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro. Slebos RJ, Kessis TD, Chen AW, Han SM, Hedrick L, Cho KR (1995) Virology 208: 111-20 Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. Sahasrabuddhe VV, Gravitt PE, Dunn ST, Robbins D, Brown D, Allen RA, Eby YJ, Smith KM, Zuna RE, Zhang RR, Gold MA, Schiffman M, Walker JL, Castle PE, Wentzensen N (2014) J Clin Virol 60: 414-7 Characterization of human papillomavirus antibodies in individuals with head and neck cancer. Lang Kuhs KA, Pawlita M, Gibson SP, Schmitt NC, Trivedi S, Argiris A, Kreimer AR, Ferris RL, Waterboer T (2016) Cancer Epidemiol 42: 46-52 [The role of oncogenic human papillomaviruses in tonsillar squamous cell carcinomas with functional inactivation of the retinoblastoma protein]. Helbig M, Andl T, Kahn T, Klein-Kühne W, Conradt C, Dietz A, Bosch FX (1999) HNO 47: 796-803
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.